Matches in Nanopublications for { ?s ?p "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1238773.RAQSFIFZnoqRj4irf6Nu5OX2CEDhssXvIJYEtN5FEvjCM130_assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238773.RAQSFIFZnoqRj4irf6Nu5OX2CEDhssXvIJYEtN5FEvjCM130_provenance.
- NP1238774.RAtLPAbL6tUi6OquQV8ajKD8u73Da8F_M4haf0E4a1xU0130_assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238774.RAtLPAbL6tUi6OquQV8ajKD8u73Da8F_M4haf0E4a1xU0130_provenance.
- NP1238776.RAjfnunUUtYJgJ3p1YUI7vmfkrk1B3iVS7fH5z8c_P2sg130_assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238776.RAjfnunUUtYJgJ3p1YUI7vmfkrk1B3iVS7fH5z8c_P2sg130_provenance.
- NP1238769.RAMUKt4cY43CQxDYu743bI6lkttiMDWELUGXF3vbVM9lE130_assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238769.RAMUKt4cY43CQxDYu743bI6lkttiMDWELUGXF3vbVM9lE130_provenance.
- NP1238770.RAOA5YGziceStAUftAcVNUzUFtLPso1OBmmP6k1ZOuxcg130_assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238770.RAOA5YGziceStAUftAcVNUzUFtLPso1OBmmP6k1ZOuxcg130_provenance.
- NP1238771.RAMLJmztXKsy9ygp71h2RloS5_WkEoyuouD6abiCG1RnY130_assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238771.RAMLJmztXKsy9ygp71h2RloS5_WkEoyuouD6abiCG1RnY130_provenance.
- NP1238768.RA2jEwr1z1J6pez3U5Nv0vPIvQd1be2SV4MoHoO9BcKtw130_assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238768.RA2jEwr1z1J6pez3U5Nv0vPIvQd1be2SV4MoHoO9BcKtw130_provenance.
- NP1238772.RA2nRVtxZl-3em3flmDZ9YXJ8ty6MA3mbR3nxGFpjoM48130_assertion description "[Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238772.RA2nRVtxZl-3em3flmDZ9YXJ8ty6MA3mbR3nxGFpjoM48130_provenance.